Cover Image

Guidance for industry : providing regulatory submissions in electronic format, general considerations.

Bibliographic Details
Corporate Authors:	Center for Biologics Evaluation and Research (U.S.), Center for Drug Evaluation and Research (U.S.), Center for Devices and Radiological Health (U.S.), Center for Food Safety and Applied Nutrition (U.S.), Center for Veterinary Medicine (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research : Center for Drug Evaluation and Research : Center for Devices and Radiological Health : Center for Food Safety and Applied Nutrition : Center for Veterinary Medicine, [2003]
Subjects:	Electronic filing systems > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS113040

Similar Items

Guidance for industry : providing regulatory submissions in electronic format, general considerations.
Published: (1999)

Guidance for industry : providing regulatory submissions in electronic format, drug establishment registration and drug listing.
Published: (2009)

Guidance for industry : providing regulatory submissions in electronic format, receipt date.
Published: (2007)

Guidance for industry : providing regulatory submissions in electronic format : human pharmaceutical product applications and related submissions using the eCTD specifications.
Published: (2008)

Guidance for industry : providing regulatory submissions to CBER in electronic format, investigational new drug applications (INDs).
Published: (2002)

Guidance for industry : providing regulatory submissions in electronic format, postmarketing indivudal case safety reports.
Published: (2008)

Guidance for industry : providing regulatory submissions in electronic format : human pharmaceutical product applications and related submissions using the eCTD specifications.
Published: (2008)

Guidance for industry : providing regulatory submissions in electronic format, prescription drug advertising and promotional labeling.
Published: (2001)

Guidance for industry : providing regulatory submissions in electronic format, content of labeling.
Published: (2005)

Guidance for industry : submitting type V drug master files to the Center for Biologics Evaluation and Research.
Published: (2001)

Guidance for industry. electronic signatures, scope and application.
Published: (2003)

Guidance for industry : part 11, electronic records : electronic signatures--scope and application.
Published: (2003)

Guidance for industry : 21 CFR, part 11, electronic records : electronic signatures, electronic copies of electronic records.
Published: (2002)

Guidance for industry : 21 CFR part 11, electronic records, electronic signatures, validation.
Published: (2001)

Guidance for industry : 21 CFR, part 11, electronic records : electronic signatures, glossary of terms.
Published: (2001)

Guidance for industry : providing regulatory submissions in electronic format, drug establishment registration and drug listing.
Published: (2008)

Guidance for industry : pharmacogenomic data submissions.
Published: (2005)

Electronic submission of hazardous waste manifests : modernizing for the 21st century : hearing before the Subcommittee on Environment and the Economy of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, June 21, 2012.
Published: (2013)

Guidance for industry : providing regulatory submissions to the Center for Biologics Evaluation and Research (CBER) in electronic format, lot release protocols.
Published: (2007)

Guidance for industry : pharmacogenomic data submissions, companion evidence.
Published: (2007)

Guidance for industry : computerized systems used in clinical trials.
Published: (1999)

Guidance for industry : format and content for the CMC section of an annual report.
Published: (1994)

Document computing : technologies for managing electronic document collections /
Published: (1998)

Guidance for industry : year 2000 date change for computer systems and software applications used in the manufacture of blood products.
Published: (1998)

Guidance for industry : dosage delivery devices for OTC liquid drug products.
Published: (2009)

Free electronic filing and national taxpayer advocate annual report : hearing before the Subcommittee on Oversight of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Eighth Congress, first session, February 13, 2003.
Published: (2003)

Free electronic filing and national taxpayer advocate annual report : hearing before the Subcommittee on Oversight of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Eighth Congress, first session, February 13, 2003.
Published: (2003)

Guidance for industry M2 : eCTD specification : questions & answers and change requests.
Published: (2005)

Ogden IRS Center presents... electronic filing, 1994.
Published: (1993)

Guidance for industry : clinical studies section of labeling for human prescription drug and biological products, content and format.
Published: (2006)

Guidance for industry : independent consultants for biotechnology clinical trial protocols.
Published: (2004)

Guidance for industry : good pharmacovigilance practices and pharmacoepidemiologic assessment.
Published: (2005)

Guidance for industry : guidance for human somatic cell therapy and gene therapy.
Published: (1998)

Guidance for industry : format and content of proposed risk evaluation and mitigation strategies (REMS), REMS assessments, and proposed REMS modifications.
Published: (2009)

Guidance for industry : guidance on the labeling of certain uses of Lecithin derived from soy under section 403(w) of the Federal Food, Drug, and Cosmetic Act.
Published: (2006)

Guidance for industry : M4Q, the CTD, quality.
Published: (2001)

Guidance for industry : available therapy.
Published: (2004)

Guidance for industry : formal meetings between the FDA and sponsors or applicants.
Published: (2009)

Guidance for industry : street drug alternatives.
Published: (2000)

Guidance for industry : considerations for developmental toxicity studies for preventive and therapeutic vaccines for infectious disease indications.
Published: (2006)